Demonstration of the Nrf2/HO-1 axis may be an important target for breast cancer treatment, as overexpression of miR-140-5p in hypoxic conditions attenuates the progression of hypoxia-induced breast cancer by reducing the expression of Nrf2 204. Here, HMOX1 is linked to breast carcinoma.